This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04156620
Recruitment Status : Completed
First Posted : November 7, 2019
Last Update Posted : February 15, 2023
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 17, 2022
Actual Study Completion Date : December 20, 2022
Certification/Extension First Submitted : October 14, 2022
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 November 24, 2023